Indian Pharma Market valued at Rs. 217,707 Cr, a growth of 7.4% as on MAT Apr'24.
Where, Apr'24 Month Valued at Rs. 19,534 Cr with growth of 8.8%.
Top Therapies (1-10)
- Cardiac recorded a growth of 15%, while Derma posted the highest growth at 12%.
Market Share Trend (1-10)
- Sun, Abbott, Mankind, Alkem, Torrent & Zydus have shown improvement in MS for Apr'24 Vs Mar’24.
- IPCA (1.93%) & Pfizer (1.49%) also showed improvement in MS for Apr’24 vs Mar’24.
Top Companies (1-20)
- Intas exhibited the highest growth (12%) for the month on MAT level.
- Glenmark saw the highest growth (19%) for the month, followed by DRL (9%).
- IPCA is the fastest-growing company on MAT level, with 12% growth.
Top Brands (1-40)
- Mixtard leads with sales of 75 Crs & MS of 0.38%.
- FORACORT follows closely with sales of 74 Crs & MS of 0.38%.
- ELECTRAL showed the highest growth of 28%, followed by PAN (19%).
Local Vs MNC Trends
- Indian companies have shown a growth of 8.9%, while MNCs registered a growth of 8.3%.
Acute Vs Chronic Trends
- Acute exhibited a growth of 6%, whereas Chronic registered growth of 13%.
Source:
- IQVIA Asia Pacific
- IQVIA Global Market Insights
